ABP
Abpro HoldingsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ABP Profile
Abpro Holdings, Inc.
A biotechnology company dedicated to developing the next generation of antibody therapies
68 Cummings Park Drive, Woburn, MA 01801
--
Abpro Holdings, Inc., was incorporated in Delaware on May 20, 2021. The company is a biotechnology company focused on developing next-generation antibody therapies designed to improve the lives of patients with serious and life-threatening diseases. Abpro focuses on novel antibody construction in immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, Abpro is developing a next-generation antibody pipeline independently or through collaborations with global pharmaceutical and research institutions.
